No Data
Why Astrazeneca (AZN) Outpaced the Stock Market Today
AstraZeneca Hits 4-week Low
The prospects of European Medical Care stocks are complex, with USA policies and new drug trial results being the key factors.
After falling from a high position in the last few months of 2024, European Medical Care stocks face the risks of US politics and the results of high-risk new drug trials in the new year.
AstraZeneca's Alexion Inks Deal With Pan-Canadian Pharmaceutical Alliance
European Equities Traded in the US as American Depositary Rise in Wednesday Trading
Merck-Hansoh Deal for Oral GLP-1 Hurts Obesity Drug Developers
loading...
Just Care Bears : I thought there’s a FDA approval going on on this today no news yet
Claudius NJIE Just Care Bears : yes good news is coming.
Claudius NJIE : pls run to at least 50